Clinicopathologic Features of Large B-cell Lymphomas with Concurrent Cytogenetic Abnormalities in MYC and BCL2: Improved Clinical Behavior with Modern Interventions

被引：0

作者：

Lee, Yi-Shan ^{[1
]}

Frater, John L. ^{[1
]}

Kreisel, Friederike H. ^{[1
]}

Ruzinova, Marianna B. ^{[1
]}

Hassan, Anjum ^{[1
]}

机构：

[1] Washington Univ, Sch Med, St Louis, MO USA

来源：

LABORATORY INVESTIGATION | 2016年 / 96卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1413

引用

页码：357A / 358A

页数：2

共 50 条

[21] CONCURRENT BCL2 AND MYC TRANSLOCATIONS IN A PROSPECTIVE COHORT OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
Gang, A. O.
Pedersen, M. O.
Poulsen, T. S.
Knudsen, H.
Lauritzen, A. F.
Talman, M. M.
Gang, U. O.
Nielsen, S. L.
Norgaard, P. H.
ANNALS OF ONCOLOGY, 2011, 22 : 109 - 109
[22] BCL2, BCL6 and CMYC abnormalities in 44 Turkish patients with diffuse large B-cell lymphomas
Kahraman, D. Solakoglu
Diniz, G.
Koca, Y.
Ekmekci, S.
Ceylan, C.
VIRCHOWS ARCHIV, 2017, 471 : S142 - S142
[23] What does MYC, BCL2, and BCL6 genes 'rearranged' mean in large cell/diffuse B-cell lymphomas?
Trombetta, Domenico
Zanelli, Magda
Garuti, Anna
Carosi, Illuminato
Mastracci, Luca
Ascani, Stefano
Graziano, Paolo
Parente, Paola
PATHOLOGY RESEARCH AND PRACTICE, 2022, 240
[24] Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
Menguy, Sarah
Frison, Eric
Prochazkova-Carlotti, Martina
Dalle, Stephane
Dereure, Olivier
Boulinguez, Serge
Dalac, Sophie
Machet, Laurent
Ram-Wolff, Caroline
Verneuil, Laurence
Gros, Audrey
Vergier, Beatrice
Beylot-Barry, Marie
Merlio, Jean-Philippe
Pham-Ledard, Anne
MODERN PATHOLOGY, 2018, 31 (08) : 1332 - 1342
[25] Double-hit and dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas
Menguy, Sarah
Frison, Eric
Prochazkova-Carlotti, Martina
Dalle, Stephane
Dereure, Olivier
Boulinguez, Serge
Dalac, Sophie
Machet, Laurent
Ram-Wolff, Caroline
Verneuil, Laurence
Gros, Audrey
Vergier, Beatrice
Beylot-Barry, Marie
Merlio, Jean-Philippe
Pham-Ledard, Anne
EUROPEAN JOURNAL OF CANCER, 2019, 119 : S20 - S20
[26] Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
Kramer, MHH
Hermans, J
Wijburg, E
Philippo, K
Geelen, E
van Krieken, JHJM
de Jong, D
Maartense, E
Schuuring, E
Kluin, PM
BLOOD, 1998, 92 (09) : 3152 - 3162
[27] Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin
Wawire, Jonathan
Sayed, Shahin
Moloo, Zahir
Sohani, Aliyah R.
JOURNAL OF GLOBAL ONCOLOGY, 2019, 5 : 1 - 8
[28] B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma
Snuderl, Matija
Kolman, Olga K.
Chen, Yi-Bin
Hsu, Jessie J.
Ackerman, Adam M.
Dal Cin, Paola
Ferry, Judith A.
Harris, Nancy Lee
Hasserjian, Robert P.
Zukerberg, Lawrence R.
Abramson, Jeremy S.
Hochberg, Ephraim P.
Lee, Hang
Lee, Alfred I.
Toomey, Christiana E.
Sohani, Aliyah R.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (03) : 327 - 340
[29] Concurrent inhibition of MYC and BCL2 is a potentially effective treatment strategy for double hit and triple hit B-cell lymphomas
Cinar, Munevver
Rosenfelt, Fred
Rokhsar, Sepehr
Lopategui, Jean
Pillai, Raju
Cervania, Melissa
Pao, Andy
Cinar, Bekir
Alkan, Serhan
LEUKEMIA RESEARCH, 2015, 39 (07) : 730 - 738
[30] C-MYC and BCL2 translocation frequency in diffuse large B-cell lymphomas: A study of 97 patients
Akkaya, Bahar
Salim, Ozan
Akkaya, Hampar
Ozcan, Mualla
Yucel, Orhan Kemal
Erdem, Ramazan
Iltar, Utku
Undar, Levent
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2016, 59 (01) : 41 - 46

← 1 2 3 4 5 →